A B S T R A C T The expression of selected lymphocyte surface-membrane markers was evaluated in 37 patients with acute viral hepatitis B, 10 of whom were studied serially through the resolving and convalescent phases of disease. Bone marrow-derived (B) lymphocytes were identified by reference to surface immunoglobulin, whereas normal thymus-derived (T) lymphocytes were assayed by their capacity to form spontaneous nonimmune rosettes with sheep erythrocytes (E rosettes, ER). During the acute and resolving phases of viral hepatitis B, the relative and absolute number of ER-positive lymphocytes was significantly reduced, whereas the number of surface immunoglobulin-positive lymphocytes and the absolute lymphocyte count remained normal. This resulted in the appearance of a third population of cells, deficient in respect to both surface immunoglobulin and ER markers. Such cells accounted for nearly 25% of peripheral blood lymphocytes, approximately 5 X 10' ml blood.
Depression of the number of ER-positive lymphocytes occurred at least once during the course of disease in every patient studied serially, and was observed in 55 of 67 individual assays of the 37 cases of acute viral hepatitis B. Lymphocytes from some patients reacquired ER function when cultured in fetal calf serum but not in the presence of autologous serum. Such autologous serum was capable of suppressing ER function of lymphocytes from normal donors. The extrinsic suppression of ER function by a serum factor (designated as the Rosette Inhibitory Factor), was found to be time dependent, characterized by a 4-h latent period and requiring approximately 18 h for maximum attenuation of ER function.
The Serum Rosette Inhibitory Factor was: (a) heat and freeze-thaw stable, (b) nondialyzable, (c) physically separable from hepatitis B surface antigen, (d) not a lymphocytotoxic antibody, and (e) had the buoyant density of a lipoprotein. This extrinsic mechanism was observed in 41 .8% of patients with reduced numbers of ER-positive lymphocytes.
The Rosette Inhibitory Factor was not detectable in the serum of the remaining 58.2% of the cases of acute and resolving viral hepatitis B despite the presence of reduced numbers of ER-positive lymphocytes. The lymphocytes from these cases did not reacquire ER function when cultured in the absence of autologous serum. The mechanisms responsible for the suppression of normal ER function in these cases appears to be intrinsic to the lymphocytes and not the result of a humoral factor. The T lymphocyte lineage of cells deficient in respect to ER function, whether of intrinsic or extrinsic type, was demonstrated by their capacity to form spontaneous rosettes with neuraminidase-treated sheep erythrocytes.
Both intrinsic and extrinsic suppression of T lymphocyte ER function commonly occurred during the first 4 wk of acute viral hepatitis B. 9 of the 10 patients followed serially continued to manifest defective ER function at 12 wk. However, the intrinsic defect was observable only in those patients whose liver disease had resolved or was resolving, whereas the extrinsic defect was observed only in two patients with biochemical and histological evidence of unresolved hepatitis at that time.
INTRODUCTION
Human thymus-derived (T) lymphocytes, the principal effectors of cellular immunity, form nonimmune rosettes
The Journal of Clinical Investigation Volume 57 May 1976. [1227] [1228] [1229] [1230] [1231] [1232] [1233] [1234] [1235] [1236] [1237] [1238] (E rosettes, ER)' with sheep erythrocytes and lack readily demonstrable high-density surface-membrane immunoglobulin (SIg) (1) . The converse is true of bone marrow-derived (B) lymphocytes, which are primarily involved in the humoral antibody response. These two types of cell-surface markers have served as primary probes for the identification of B and T lymphocytes and facilitated investigation of the cellular biology of the lymphoid system.
T-lymphocyte ER formation is an active cellular function attributable to a surface-membrane receptor (2) , and is dependent upon protein and nucleic acid synthesis (3). It is modulated by alterations in intracellular levels of cyclic nucleotides (4); and it has been found by some to parallel certain other parameters of T-lymphocyte function including phytohemagglutinin responsiveness and delayed cutaneous hypersensitivity responses in selected studies of primary immunodeficiency states (5) . The expression of ER function may serve as an index of the functional integrity of T lymphocytes, since it is defective in many disease states thought to be associated with altered or deficient cellular immune responsiveness such as malignancy (6) , systemic lupus erythematosus (7) , and viral hepatitis (8 (9) . Indeed, a similar spectrum of disease states has been induced in chimpanzees after inoculation with a single pool of HBsAg-positive plasma (10) . Thus, in hepatitis B virus infection, other factors besides the presence of virus appear to play a critical role in determining the character of the host-virus interaction and the biological sequelae of this encounter. Whereas the host may mount an immune response capable of viral neutralization, the induced immune response to the virus or to virus-induced neoantigens may 'Abbreviations used in this paper: BSA, bovine serum albumin; ER, sheep erythrocyte rosette; HBcAg, hepatitis B virus-associated core antigen; HBsAg, hepatitis B virusassociated surface antigen; nER, rosettes formed between T lymphocytes and nSRBC; nSRBC, neuraminidase-treated SRBC; PBS, phosphate-buffered saline; PSG, Puck's saline G; RIF, Rosette Inhibitory Factor; SGOT, serum glutamic-oxaloacetic transaminase; SIg, surface membrane immunoglobulin; SRBC, sheep red blood cell.
play an integral role in the pathogenesis of the associated tissue injury (11, 12) . These relationships and interactions are complicated by the reported suppressive effects of viruses on lymphocyte function (13, 14) as well as of viral infection on the immune response (15) .
In the present study, we have focused our attention on the susceptibility of T-lymphocyte ER function to modulation during hepatitis B virus infection. We have discovered that the decrease in ER-positive lymphocytes characteristic of this disease is due to defective expression of ER function by circulating T lymphocytes rather than peripheral T lymphocytopenia. Two mechanisms responsible for suppression of T-lymphocyte ER function have been identified. A possible relationship between these mechanisms and the pathobiology of the associated disease has been suggested.
METHODS
Selection of patients. Young, adult, Caucasian men who were admitted to the hepatitis ward of the U. S. Naval Regional Medical Center, San Diego within 5 days of the onset of jaundice, and who were, at that time, serologically positive for the presence of HBsAg were requested to voluntarily enter the study. Informed consent was obtained, and 37 patients were studied. 10 were evaluated serially for a minimum of 12 wk. The remaining 27 were evaluated once or twice during the acute phase of viral hepatitis B. No medications other than occasional doses of aspirin and prochlorperazine were administered and these were withheld for 24 h before the lymphocyte studies.
Patient evaluation. In each case a diagnosis of acute viral hepatitis type B was made according to standard clinical criteria, including history and physical examination, complete blood count, urinalysis, and liver function tests consisting of determination of serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic-pyruvic transaminase, direct and indirect bilirubin, and prothrombin time. Serum was obtained weekly for the quantitation of HBsAg by counterimmunoelectrophoresis (16) until negative results were obtained. Negative sera were confirmed by solid-phase radioimmunoassay (Austria, Abbott Laboratories, South Pasadena, Calif.). Antibody to HBsAg was determined by fluid-phase radioimmunoassay of double-antibody type (17) . Percutaneous Menghini needle liver biopsies were obtained from the 10 patients followed serially at 3 and 12 wk after admission. The tissue was fixed in 10% formalin, and stained with hematoxylin and eosin as well as by reticulin and trichrome methods following routine processing.
Isolation of lymphocytes. Lymphocytes wereisolatedfrom peripheral blood collected into preservative-free heparin, as previously described (4) . Briefly, the blood was mixed immediately in a syringe with 3.5 vol of carbonyl irondextran (Lymphocyte separating reagent, Technicon Instrument Corp., Tarrytown, N. Y.) and incubated at 370C for 10 min, followed by 30 min at 220C with slow inversion on a turntable mixer (10 rpm Kaplow (18) . In the eight subjects studied, 0.6±0.6%
of the mononuclear cells were peroxidase positive (range 0.0-1.8%) which suggests that 99.4% of the isolated mononuclear cells are lymphocytes.
Assay of SIg-positize lymphocytes. The lymphocytes were assayed for SIg in the cold (0-40C) as previously described (4) . To each of six tubes which contained 1.5-2 X 106 lymphocytes and approximately 2 X 107 carrier erythrocytes was added 50 pzl of a fluorescein-conjugated antiimmunoglobulin reagent of given specificity: IgG (-y-chain), IgA (a-chain), IgM (Ai-chain), K-light chain, X-light chain, or Ig polyvalent, in 1% BSA-PSG, 0.03%o sodium azide.
After 30-min incubation of 0C, the cells were washed two times in 1% BSA-PSG, once in 5%y BSA-PSG, and the pellet was smeared on slides as for the preparation of blood smears.
The slides were dried overnight, fixed for 3 min in absolute methanol, stained for 5 min with acridine orange (0. 35 Aig/ml, 0.1 M Tris-HCl, pH 8.0) to provide a faint counterstain, washed in distilled water and mounted in 1%o TrisHCl, pH 9.5, 90% glycerol. Slides were examined with a Zeiss RA microscope (Carl Zeiss, Inc., New York) equipped with HB-200 mercury arc illumination, no heat filter, a 490-nm interference type excitation filter, a NA 1.2-1.4 dark-field condenser, and a 530-nm barrier filter. SIg was scored from examination of 400 lymphocytes. Contaminating polymorphonuclear leukocytes were excluded cytologically by means of the faint acridine orange fluorescence of nuclei which is photo-inactivated within 3-5 s.
Fluorescein-conjugated reagents for SIg staining were prepared from specific antisera raised in goats or rabbits. Antisera to IgA and IgM were prepared by hyperimmunization of goats at monthly intervals with 100 jig of a mixture of highly purified immunoglobulin of appropriate class in incomplete adjuvant. Antisera to IgM and to IgA were absorbed with IgG. Antiserum to IgG was prepared by immunization with the Fc fragment of IgG (19) and was absorbed with F (ab')2. Each antiserum appeared specific by Ouchterlony and immunoelectrophoretic analyses and the lack of reactivity with purified immunoglobulins of the other classes coupled to Sepharose 4B beads (Pharmacia Fine Chemicals Inc., Piscataway, N. J.) with cyanogen bromide (20) . Anti-Ig polyvalent was prepared by chronic immunization of a single goat with 100 jig each of IgG, IgA, IgM, IgD, K-, and X-light chains. The antiserum reacted with each of these classes of immunoglobulin and with light chains. Reactions with other serum proteins were not observed. Rabbit antiserum to X-light chains and goat antiserum to K-light chains (Meloy Laboratories Inc., Springfield, Va.) appeared specific for monoclonal immunoglobulins of appropriate light chain type by Ouchterlony analysis.
I
The gamma globulin fractions of the antisera were precipitated at 50%o saturation with ammonium sulfate at 4°C and redissolved in 0.14 M NaCl, 0.01 M sodium phosphate, z pH 7.3 (phosphate-buffered saline [PBS]). After three i cycles of precipitation, the gamma globulin fraction was dialyzed against PBS and the protein (at 10 mg/ml) was conjugated with fluorescein isothiocyanate by dialysis (21) at 4°C for 20 h using 10 mg fluorescein isothiocyanate/ml protein solution. After dialysis against PBS, and absorption with 50 mg of guinea pig liver acetone powder/ml, the preparations were brought to 20% sucrose and clarified by ultracentrifugation at 68,000 g for 18-20 h. The monomeric 7S fraction was isolated by Sephadex G-200 (Pharmacia Fine Chemicals Inc.) chromatography and the FITC to protein molar ratio was determined spectrophotometrically to be approximately 5-6: 1 (22) . Each standard was utilized after repeated titration (23) to determine the concentration required to give a constant percentage of SIg' cells.
Each reagent gave a single plateau of constant percentage of SIg' cells over a three-to fivefold range of concentration of reagent. The reagents were diluted in 1% BSA-PSG, 0.03%o sodium azide. Purified antibody reagents were prepared from standard reagents by absorption to immunoabsorbents and elution with 3.5 M potassium iodide in 0.1%o BSA, 0.01 M Tris-HCI, pH 8.0 (24), followed by gel filtration on Sephadex G-200 to recover the 7S fraction. The latter reagents were dialyzed, concentrated, and titered against normal peripheral blood lymphocytes as above. They gave results indistinguishable from the standard reagents. Specificity of each of the reactions was confirmed by neutralization of the reagents with specific soluble immunoglobulin or specific immunoglobulin coupled to Sepharose (25) .
F (ab')2 fragments of an independent anti-immunoglobulin antiserum reactive with all classes of immunoglobulin were prepared by pepsin cleavage according to Nisonoff et al. (26) . This reagent was shown to be free from residual undigested IgG and contaminating Fc fragments by molecular exclusion chromatography on Sephadex G-150, Ouchterlony analysis, and immunoelectrophoresis, and was conjugated with fluorescein isothiocyanate as described above. The reagent was titrated as above and the plateau for SIg+ cells was employed in assays.
ER assay. Assay was that of Jondal et al. (1) , performed as previously described (4) . A lymphocyte-rich plasma depleted of phagocytic cells was produced as above with carbonyl iron from 2 ml of blood. The cells were sedimented for 10 min at 400 g and were then suspended in Serum-mediated inhibition of ER function. Assay was performed as previously described (27) . Briefly, lymphocytes were isolated from the peripheral blood of normal donors according to the method of Boyum (28) Lymphocytes were suspended at 1 X 106/ml in RPMI-1640 supplemented with penicillin, streptomycin, and l-glutamine as above and 2-ml aliquots were dispensed into 12 X 75-mm sterile polypropylene culture tubes. Individual cultures received 0.5 ml of either normal autologous donor serum or test serum drawn at the time of the initial lymphocyte studies. After incubation for 24 h at 370C in a humid atmosphere containing 5%o CO2 in air, pH 7.35 to 7.45, the cells were washed three times with RPMI-1640 at 250 g for 20 min and adjusted to a concentration of 1 X 108 cells/ ml (viability > 95%, yield of cells > 85%). Experiments were performed in duplicate. Cells were assayed for SIg and ER markers.
The SD within individual assays was usually i 2-3%o and always less than ±5%o. The %ER+ lymphocytes after cultivation in test serum was compared with the %ER+ obtained after cultivation in control serum. The result was expressed as relative percent inhibition of ER function induced by test serum and was calculated as follows: %o inhibition = (C -X)/C X 100, where C equals %ER+ cells cultured in control serum (60-75%o) and X equals %c'ER+ lymphocytes after culture in test serum. Significant inhibition was considered to be present if C differed from X by at least 2 SD.
Assay for nER+ lymphocytes. T lymphocytes were also identified by reference to their capacity to form rosettes (nER) with neuraminidase-treated SRBC (nSRBC) (29) .
1 ml of 5% ,SRBC in RPMI-1640 was incubated with 75 jul of neuraminidase (500 U/ml) for 30 min at 370C, washed with PSG and adjusted to a 0.5%o concentration. To 250 /Al of nSRBC was added 0.5 X 106 lymphocytes suspended in 250 ju of PSG. The mixture was incubated at 370C for 10 min and centrifuged at 200 g for 5 min. The pellet was kept at room temperature for 60 min, at which time it was gently resuspended and the %nER+ lymphocytes were counted as for assay of ER+ cells.
Lymphocytotoxicity studies. All sera were tested for cytotoxic activity against the donor lymphocytes used in the Rosette Inhibitory Factor (RIF) assays according to a modification of the microcytotoxicity method of Mittal etal. (30) . Target lymphocytes were provided by the same individuals whose lymphocytes were used in the RIF assays. Incubation with test sera for 2 h at 40 and 250C was followed by the addition of complement (rabbit serum that had been evaluated for use in lymphocytotoxicity assays [311 was generously supplied by Dr. Soldano Ferrone) and further incubation at room temperature for an additional 2 h. The percent of cytotoxicity was determined by microscopic determination of dye exclusion (eosin yellow). A minimum of 300 cells was counted for each condition and assays were performed in duplicate.
Antitissue antibody determinations. The presence of antitissue antibodies was evaluated (32 (Table  II) .
Intrinsic and extrinsic mechanisms responsible for the induction of defective T-lymphocyte ER function. When lymphocytes from 17 patients with defective T-lymphocyte ER function were washed free of serum constituents, incubated for 24 h in the presence of either fetal calf serum or autologous serum, and reexamined for the expression of SIg and ER, they were found to be separable into two distinct categories (Table III) . Seven of these cases (group 1) displayed a significant (P < 0.005) increase in ER+ lymphocytes after cultivation in fetal calf serum, whereas no significant increase in ER+ (Table IV) .
The ER function of normal lymphocytes cultivated in the presence of serum from patients in group 1 with an extrinsic defect in ER function was reduced by greater than 2 SD in comparison with aliquots of the same lymphocytes cultured in control serum. In contrast, no reduction in the %ER' lymphocytes was observed when the same cells were cultivated with sera from patients in group 2 with an intrinsic defect, group 3, or normal controls.
Direct evidence that lymphocytes with intrinsic and extrinsic defects in ER function possess T-lymphocyte surface markers. Lymphocytes from patients with both Relationship between RIF and HBsAg. 1 ml each of three HBsAg-positive sera, also positive for RIF activity, was centrifuged at 114,000 g at 40C for 90 min to pellet the HBsAg. The sera were recovered in two 0.5-ml fractions and were assayed for HBsAg and for RIF activity (Table VII) . 80% of the HBsAg was recovered in the pellet, whereas RIF activity was recovered in the supernatant fractions. RIF appeared to be concentrated in the supernate as indicated by the increased RIF activity as compared to the same volume of the initial serum. In separate studies, RIF was found to possess the buoyant density of low density lipoprotein Incubation Time (hours) FIGURE 1 Effect of group 1 and group 2 sera on ER function of normal T lymphocytes. Sera from six group 1 patients with an extrinsic lymphocyte defect were incubated with normal lymphocytes for the times indicated. The lymphocytes were washed and ER function was assessed. Sera from six group 2 patients possessing an intrinsic lymphocyte defect were also assayed. Results were compared with the ER function of lymphocytes cultured in normal autologous serum. Shaded area, group 1 sera; crosshatched area, group 2 sera.
(1.050±0.004 g/cm3) and to be devoid of nonlipoprotein constituents by biochemical and immunochemical techniques (27) .
Properties of RIF activity. Fresh serum samples in which RIF activity was detectable were repeatedly frozen and thawed without loss of RIF activity. Three RIF+ sera were heated at 560C for 45 min without loss of activity. No loss of RIF activity was observed after dialysis of three additional RIFP sera against PBS, pH 7.4.
Lymphocytotoxic activity, immunoglobulin concentration, and antitissue antibodies in sera with and without RIF activity. None of the sera in this study were di- rectly cytotoxic for the standard normal lymphocytes used in the RIF assay as determined by trypan blue exclusion. Complement-dependent lymphocytotoxicity assays were performed to assess the presence of antilymphocyte antibodies which might have been responsible for the RIF effect. None of the RIFP sera were cytotoxic for any of the standard normal lymphocytes used in the RIF assays. Serum levels of IgG, IgA, and IgM were determined weekly for the first month of the study and subsequently at the time of the B-and T-lymphocyte evaluation. No significant or consistent changes were noted.
Serum samples obtained at the time of each lymphocyte study were also examined for the presence of antinuclear, antimitochondrial, antismooth muscle, and antiparietal cell antibodies. All samples were negative at a dilution of 1: 10.
Classification of patients according to type of defect in ER function. 67 serum samples obtained from 37 patients at the time of lymphocyte assay were analyzed for RIF activity. RIF was present in 23 of the 55 cases with defective ER function (41.8%) and absent in the remaining patient groups and controls. The patients could be resolved into three categories on the basis of the presence of defective ER function and serum RIF activity (Table VIII) .
The lymphocytes from all patients in group 1 had defective ER function and serum RIF activity was simultaneously present. Lymphocytes from seven of these patients were assayed for ER function after cultivation in the absence of autologous serum (see also Table IV) and all seven displayed the ability to regenerate ER function under these conditions.
The lymphocytes from all patients in group 2 had defective ER function but serum RIF activity was absent. Regeneration of ER function was not demonstrable in any of the 10 cases from this group in which it was assayed. These data suggest that the coexistence of serum RIF activity and deficient ER function is causal and suggest that an extrinsic mechanism is responsible for defective T-lymphocyte function in these patients. In the absence of serum RIF activity other mechanisms must be implicated and these may be intrinsic to the lymphocyte.
Association of intrinsic and extrinsic defects in ER function with the course of the acute viral hepatitis B. Among 10 patients followed serially through the course of acute viral hepatitis B and recovery (Table IX) (9) . The possibility that such defective lymphocytes might represent monocytes is rendered unlikely by the demonstrated effectiveness of the iron-dextran lymphocytes isolation method to reduce peroxidase-positive cells (18) to less than 1%.
The existence of multiple mechanisms for modification of T-lymphocyte ER function is consistent with the observations that this function depends upon critical metabolic processes including oxidative phosphorylation (35) , glycolysis (1) , microfilament function (36) , protein and nucleic acid synthesis (3), divalent cation concentration (36) , and cyclic nucleotide levels (4 (50) , and other viral infections (6) .
It is now evident that defective (ER-) T lymphocytes occur at one time or another in every patient studied, and they have persisted for at least 12 wk after the onset of jaundice in 9 of 10 subjects followed serially. A distinction was observed between two patients with unresolved hepatitis and eight others whose illness was resolved or resolving. The T lymphocytes from patients with unresolved hepatitis displayed an extrinsic defect at every sampling interval. In contrast, none of the 8 patients with transient disease had an extrinsic T-lymphocyte defect, or RIF at 12 wk. Further long-term clinical studies will be required in order to establish the consistent association of the extrinsic mechanism and RIF with the development and course of chronic hepatocellular injury after hepatitis B virus infection.
The existence of a new serum factor, RIF, evolved during this study. This represents a substance(s) in the serum of patients with an extrinsic T-lymphocyte defect which suppresses T-lymphocyte ER function in vitro, and presumably in vivo as well. Normal serum does not correct the effect of RIF, which suggests that this effect does not reflect absence of a normal factor required for ER expression, but rather the presence of a suppressive factor. That RIF exerts a metabolic effect, rather than simple steric hindrance is suggested by the 4-h latent period and the time-dependent attenuation of ER function during cultivation. A similar delayed inhibition of ER function is seen when lymphocytes are incubated in vitro with cholera enterotoxin, an agent known to induce a delayed rise in intracellular adenyl cyclase and cyclic AMP levels (4). The partial rather than complete inhibition of ER function may reflect the concentration of RIF, subsets of T lymphocytes differing in ER function or susceptibility to RIF. Heterogeneity of ER function is indicated inasmuch as only 25 (27) . Whether RIF represents viral-coded lipoprotein, molecular debris resulting from hepatocellular injury, or an independent entity must be established.
The occurrence of immunoregulatory factors in human serum has been suggested by a number of investigators (52) (53) (54) (55) (56) (57) (58) . RIF does not appear to be identical to previously described immunoregulatory factors. It is nondialyzeable, which suggests that it is neither an immunoregulatory a-globulin peptide (57, 58) nor an adrenocortical steroid (55) . RIF+ sera are not directly cytotoxic for the donor lymphocytes used in the RIF assay, nor do they mediate complement-dependent cytotoxicity against these lymphocytes, which suggests that lymphocytotoxic antibodies (52, 53) are not responsible for RIF effect. The physicochemical properties of RIF (27) clearly distinguish it from immunoglobulins, immunoregulatory a-globulin (56) , and other serum glycoproteins (54), but rather establish RIF as a bioregulatory lipoprotein.
The present study indicates that infection with the hepatitis B virus is associated with two distinctive types of defective T-lymphocyte function. The mechanisms responsible for the induction of these defects appear to be quite independent, and it is suggested that one type of defect attributable to a serum factor may be associated with protracted disease. Further elucidation of these mechanisms may eventually provide a cogent basis for understanding the immunobiology of the host, his re-1236 F. V. Chisari, J. A. Routenberg, and T. S. Edgington sponse to the challenge of viral infection, and the pathogenetic basis for diseases associated with potentially persistent noncytopathic viral agents (59) .
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